Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Blindness in leprosy patients
G-probe barrier successful
Post-VRS bleeding
Ozurdex and macular oedema
Survey

Do you prefer to use RNFL3.45 or NHM4 to measure retinal nerve fibre layer thickness?

RNFL3.45
52%
NHM4
48%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

June 15, 2011
High prevalence of blindness and ocular complications in leprosy patients
Data presented in an advance on-line publication of the journal Eye has shown a high occurrence of ocular conditions in UK leprosy patients. More...
Safe and effective barrier against contamination during TSCPC
Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients. More...
Surgical video competition update
Would you like to be in with a chance to win a ZEISS Cinemizer and an iPod Touch?

For more information click here...
Anticoagulant poses higher risk for post-op bleeding in VRS
Anticoagulation (warafin) therapy was linked to a higher risk of post vitreoretinal surgery (VRS) bleeding in comparison with antipletelet (aspirin, clopidogrel) therapy according to recent data. More...
Ozurdex recommended for treating macular oedema
The National Institute for Health and Clinical Excellence (NICE) has recommended Ozurdex for the treatment of macular oedema caused by central retinal vein occlusion (CRVO). More...

 

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH. United Kingdom